[HTML][HTML] Advancing targeted protein degradation for metabolic diseases therapy
QQ Zhou, HT Xiao, F Yang, YD Wang, P Li… - Pharmacological …, 2023 - Elsevier
The development and application of traditional drugs represented by small molecule
chemical drugs and biological agents, especially inhibitors, have become the mainstream …
chemical drugs and biological agents, especially inhibitors, have become the mainstream …
[引用][C] Advancing targeted protein degradation for metabolic diseases therapy
QQ Zhou, HT Xiao, F Yang, YD Wang, P Li… - Pharmacological …, 2023 - cir.nii.ac.jp
Advancing targeted protein degradation for metabolic diseases therapy | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Advancing targeted protein degradation for metabolic diseases therapy.
QQ Zhou, HT Xiao, F Yang, YD Wang, P Li… - Pharmacological …, 2022 - europepmc.org
The development and application of traditional drugs represented by small molecule
chemical drugs and biological agents, especially inhibitors, have become the mainstream …
chemical drugs and biological agents, especially inhibitors, have become the mainstream …
Advancing targeted protein degradation for metabolic diseases therapy
QQ Zhou, HT Xiao, F Yang, YD Wang… - Pharmacological …, 2023 - pubmed.ncbi.nlm.nih.gov
The development and application of traditional drugs represented by small molecule
chemical drugs and biological agents, especially inhibitors, have become the mainstream …
chemical drugs and biological agents, especially inhibitors, have become the mainstream …